Using these five sites on FZD10 and NOTCH1 as criteria, the high-difference change group exhibited a significantly better prognosis than the low-difference (shallow) change group, indicating a negative impact of the tumor on surrounding tissue. This evidence concerns the gene NOTCH1 and neoplasm.